Bullous pemphigoid in lepromatous leprosy.
Thappa
D M
DM
Department of Dermatology and STD, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry.
Rao
M V
MV
Garg
B R
BR
Ratnakar
C
C
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002991:Clofazimine / Q000627:therapeutic use; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use; D015440:Leprosy, Lepromatous / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use; D012872:Skin Diseases, Vesiculobullous / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D007917:Leprostatic Agents; D002991:Clofazimine; D013752:Tetracycline; D012293:Rifampin